Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States.

[1]  P. Fockens,et al.  Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[2]  P. Moayyedi,et al.  Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial , 2008, The American Journal of Gastroenterology.

[3]  R. Soiffer,et al.  Individual physician practice variation in hematopoietic cell transplantation. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  J. Going,et al.  Systematic Four-Quadrant Biopsy Detects Barrett's Dysplasia in More Patients Than Nonsystematic Biopsy , 2008, The American Journal of Gastroenterology.

[5]  W. Tsai,et al.  Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. , 2008, Journal of the National Cancer Institute.

[6]  D. Stewart,et al.  Influence of physician and patient characteristics on adherence to breast cancer screening recommendations , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[7]  V. Beral,et al.  Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study , 2007, BMJ : British Medical Journal.

[8]  T. Ponchon,et al.  Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus. , 2007, Journal of evaluation in clinical practice.

[9]  G. Block,et al.  Abdominal obesity and body mass index as risk factors for Barrett's esophagus. , 2007, Gastroenterology.

[10]  L. Doucet,et al.  Prevalence and topography of intestinal metaplasia in columnar lined esophagus. , 2007, Gastroenterologie clinique et biologique.

[11]  Keith Abrams,et al.  Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.

[12]  R. Goldbohm,et al.  Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study , 2007, Gut.

[13]  D. Faigel,et al.  Quality Indicators for Esophagogastroduodenoscopy , 2006, The American Journal of Gastroenterology.

[14]  H. Wolfsen,et al.  Barrett's Esophagus Is Common in Older Men and Women Undergoing Screening Colonoscopy Regardless of Reflux Symptoms , 2006, The American Journal of Gastroenterology.

[15]  N. Shaheen.  Advances in Barrett's esophagus and esophageal adenocarcinoma. , 2005, Gastroenterology.

[16]  G. Tytgat,et al.  New developments in the endoscopic surveillance of Barrett’s oesophagus , 2005, Gut.

[17]  H. Welch,et al.  The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. , 2005, Journal of the National Cancer Institute.

[18]  H. Sue-Ling,et al.  Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer , 2004, The British journal of surgery.

[19]  O. Cummings,et al.  Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. , 2003, Gastroenterology.

[20]  R. Playford,et al.  Current practice in surveillance strategy for patients with Barrett's oesophagus in the UK , 2003, Alimentary pharmacology & therapeutics.

[21]  D. Corley,et al.  Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States , 2002, Cancer.

[22]  Noel S Weiss,et al.  Surveillance and survival in Barrett's adenocarcinomas: a population-based study. , 2002, Gastroenterology.

[23]  L. Bonavina,et al.  Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus , 2002, Surgical Endoscopy And Other Interventional Techniques.

[24]  J K Greenson,et al.  Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.

[25]  N. Shaheen,et al.  The quality of care in Barrett’s esophagus: endoscopist and pathologist practices , 2001 .

[26]  G. Falk,et al.  Practice patterns for surveillance of Barrett's esophagus in the united states. , 2000, Gastrointestinal endoscopy.

[27]  R. Cherian,et al.  Prospective evaluation of the prevalence of gastric helicobacter pylori infection in patients with GERD, barrett's esophagus, barrett's dysplasia, and barrett's adenocarcinoma , 2000, American Journal of Gastroenterology.

[28]  J. Bartelsman,et al.  Surveillance of Barrett's oesophagus: physicians' practices and review of current guidelines , 2000, European journal of gastroenterology & hepatology.

[29]  A. Weston,et al.  Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma , 1999, American Journal of Gastroenterology.

[30]  R. Wong,et al.  Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. , 1999, Gastroenterology.

[31]  G. Tytgat,et al.  Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.

[32]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[33]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[34]  M. Gammon,et al.  Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. , 1997, Journal of the National Cancer Institute.

[35]  A. Cameron,et al.  Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. , 1997, The American journal of gastroenterology.

[36]  R. Cherian,et al.  Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: comparison with traditional long segment Barrett's esophagus. , 1997, The American journal of gastroenterology.

[37]  J. Peters,et al.  Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.

[38]  F. Ellis,et al.  Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.

[39]  K. Lewin,et al.  Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. , 1992, Human pathology.

[40]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[41]  E. Feuer,et al.  SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD, , 2006 .

[42]  R. Fitzgerald,et al.  Epidemiologic risk factors for Barrett's esophagus and associated adenocarcinoma. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  M. Ferguson,et al.  Long-term survival after esophagectomy for Barrett’s adenocarcinoma in endoscopically surveyed and nonsurveyed patients , 2002, Journal of Gastrointestinal Surgery.

[44]  B. Reid,et al.  Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. , 1988, Gastroenterology.